DMK
TPST icon

David M. Knott’s Tempest Therapeutics TPST Stock Holding History

David M. Knott’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,064
Closed -$155K – 156
2021
Q2 		$155K Buy
1,064
+357
+50% +$80.2K 0.06% 105
2021
Q1 		$165K Buy
+707
New +$286K 0.07% 90
2018
Q2 		– Sell
-38
Closed -$91K – 115
2018
Q1 		$91K Hold
38
– – 0.04% 87
2017
Q4 		$157K Sell
38
-9
-19% -$37.8K 0.06% 81
2017
Q3 		$196K Buy
47
+42
+840% +$180K 0.08% 77
2017
Q2 		$25K Buy
+5
New +$21.2K 0.01% 83

Other funds holding TPST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

David M. Knott's TPST Position: Q3 2021 in Review

David M. Knott sold out of Tempest Therapeutics (TPST) in Q3 2021, closing a stake of 1,064 shares — an estimated $155K sold.

David M. Knott first reported a position in TPST in Q2 2017 and held it in 6 quarters. The position peaked at $196K in Q3 2017. 20 funds tracked by Wall St. Rank hold TPST as of Q3 2021.

  • David M. Knott reported no remaining Tempest Therapeutics position as of Q3 2021 after selling out during the quarter.
  • David M. Knott sold 1,064 Tempest Therapeutics shares in Q3 2021, an estimated $155K.
  • David M. Knott first reported a position in Tempest Therapeutics in Q2 2017 and held it in 6 quarters.
  • David M. Knott's Tempest Therapeutics position peaked at $196K in Q3 2017.
  • 20 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q3 2021.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.